Integrated Diagnostics Holdings stock analysis
Integrated Diagnostics Holdings (IDGXF) Stock Price & Analysis
IDGXF Stock Chart & Stats
- Day’s Range
- $0.47 - $0.47
- 52-Week Range
- $0.46 - $0.83
- Previous Close
- $0.47
- Volume
- N/A
- Average Volume (3M)
- 310
- Market Cap
- $279.04M
- Enterprise Value
- $199.41M
- Total Cash (Recent Filing)
- $1.96B
- Total Debt (Recent Filing)
- $1.68B
- Price to Earnings (P/E)
- 9.7
- Beta
- 0.75
- Next Earnings
- Nov 12, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- May 29, 2026
- Dividend Yield
- 5.36%
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Patient Growth
Rapid growth in revenue, testing volume, and patients served indicates expanding utilization and stronger market reach. The combination of higher volumes and increased revenue per test supports durable operating leverage and gives IDH a broader base for continued growth.
Healthy And Improving Profitability
Strong profit growth alongside revenue growth demonstrates that IDH is converting scale into earnings rather than relying solely on expansion. Improved gross and net margins, supported by cost discipline and operating leverage, strengthen the company’s capacity to reinvest.
Expanding Diagnostic Network And Services
A larger branch network and broader diagnostic offering can deepen patient access, referral relationships, and cross-service utilization. Expansion across laboratory, radiology, and radiotherapy also increases the platform’s relevance to healthcare providers and patients.
Bears Say
Working Capital Is Absorbing More Cash
Rising receivables and inventory require more cash to support each unit of revenue, which can weaken cash conversion even while accounting profits grow. Sustained working-capital intensity could limit internally funded expansion and reduce financial flexibility.
Saudi Arabia Remains Below Break-Even
Saudi expansion offers long-term growth potential, but the operation is still consuming resources before reaching profitability. Continued branch openings may increase the duration and scale of investment needs, making group earnings more dependent on successful utilization gains.
Lower Net Cash And Financial Flexibility
A materially lower net cash position reduces the cushion available for expansion, unexpected operating pressure, or regional disruption. Although the business remains profitable, less liquidity can constrain capital allocation choices and increase reliance on disciplined cash management.
Integrated Diagnostics Holdings News
IDGXF FAQ
What was Integrated Diagnostics Holdings’s price range in the past 12 months?
What is Integrated Diagnostics Holdings’s market cap?
When is Integrated Diagnostics Holdings’s upcoming earnings report date?
Is Integrated Diagnostics Holdings overvalued?
Does Integrated Diagnostics Holdings pay dividends?
What is Integrated Diagnostics Holdings’s EPS estimate?
How many shares outstanding does Integrated Diagnostics Holdings have?
Which hedge fund is a major shareholder of Integrated Diagnostics Holdings?
What is the TipRanks Smart Score and how is it calculated?
Integrated Diagnostics Holdings Stock Smart Score
Company Description
Integrated Diagnostics Holdings
Integrated Diagnostics Holdings plc (IDHC.L) functions as a leading consumer healthcare enterprise, offering a wide array of medical diagnostic services directly to its clientele. The company's comprehensive service catalog features around 2,000 distinct diagnostic examinations, spanning specialized fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. Geographically, IDHC has established operations across Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, its infrastructure included an extensive network of 452 laboratory branches. The organization was founded in 1979 and maintains its corporate headquarters in Saint Helier, Jersey.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Hend El Sherbini
- Employees
- 7,137
- Website
- www.idhcorp.com
- Address
- 12 Castle Street, Saint Helier, GZ, JE2 3RT, JE
Integrated Diagnostics Holdings (IDGXF) Earnings & Revenues
IDGXF Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Highlights significantly outweighed the lowlights, with 37% revenue growth, record testing volume, expanding margins, 47% net profit growth, improved Nigeria performance, and rapid Saudi expansion. The main challenges were geopolitical uncertainty, constrained Sudan operations, Saudi Arabia remaining below break-even, higher working capital balances, lower net cash, and the decision not to pay an interim dividend.
View all IDGXF earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |










